Biogen Net Income From Continuing Ops from 2010 to 2026
| IDP Stock | EUR 158.65 0.05 0.03% |
Net Income From Continuing Ops | First Reported 2017-03-31 | Previous Quarter 466.5 M | Current Value -48.9 M | Quarterly Volatility 515.3 M |
Check Biogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biogen's main balance sheet or income statement drivers, such as Interest Expense of 171.9 M, Selling General Administrative of 2.5 B or Total Revenue of 9.1 B, as well as many indicators such as . Biogen financial statements analysis is a perfect complement when working with Biogen Valuation or Volatility modules.
Biogen | Net Income From Continuing Ops |
The Net Income From Continuing Ops trend for Biogen Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Biogen is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Biogen's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Biogen Inc over the last few years. It is Biogen's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biogen's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Biogen Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 2,957,201,569 | |
| Geometric Mean | 2,725,151,006 | |
| Coefficient Of Variation | 40.29 | |
| Mean Deviation | 815,328,305 | |
| Median | 2,941,600,000 | |
| Standard Deviation | 1,191,352,141 | |
| Sample Variance | 1419319.9T | |
| Range | 4.7B | |
| R-Value | (0.35) | |
| Mean Square Error | 1323422.3T | |
| R-Squared | 0.13 | |
| Significance | 0.16 | |
| Slope | (83,692,124) | |
| Total Sum of Squares | 22709118.8T |
Biogen Net Income From Continuing Ops History
About Biogen Financial Statements
Biogen stakeholders use historical fundamental indicators, such as Biogen's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Biogen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biogen's assets and liabilities are reflected in the revenues and expenses on Biogen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biogen Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 1.3 B | 2.4 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Biogen Correlation against competitors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.